4//SEC Filing
Pfeffer Cary 4
Accession 0000899243-21-044914
CIK 0001640455other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:54 PM ET
Size
7.4 KB
Accession
0000899243-21-044914
Insider Transaction Report
Form 4
Pfeffer Cary
Director
Transactions
- Sale
Common Stock
2021-11-12−0→ 0 total(indirect: See Footnote)
Holdings
- 0(indirect: See Footnote)
Common Stock
- 50,468
Common Stock
Footnotes (4)
- [F1]On November 12, 2021, Third Rock Ventures III, L.P. ("TRV III") sold 1,900,000 shares of Common Stock of the Issuer at an average price per share of $8.38.
- [F2]After the above transaction, TRV III owned 1,148,780 shares of Common Stock of the Issuer.
- [F3]The Reporting Person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]Third Rock Ventures II, L.P. ("TRV II") directly holds 2,697,829 shares of the Issuer's Common Stock. The Reporting Person is a partner of Third Rock Ventures GP II, L.P., which is the general partner of TRV II. The Reporting Person disclaims beneficial ownership over the shares held by TRV II, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001591092
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 7:54 PM ET
- Size
- 7.4 KB